This inventor holds 3 USPTO granted patents. Top assignee: American Cyanamid Company. Active years: 1976-1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1978
Title: The Innovations of Robert Zalmon Gussin
Introduction
Robert Zalmon Gussin is a notable inventor based in Suffern, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of diuretics. With a total of 3 patents to his name, Gussin's work has had a meaningful impact on medical treatments.
Latest Patents
Gussin's latest patents include a method for antagonizing aldosteronic action and inducing diuresis through novel 1-(phenyl or p-chlorophenyl)-2,4-disubstituted-3-methylimidazolidines. He has also developed a method for inducing diuresis and treating hyperaldosteronism by the administration of tetrasubstituted imidazolidine diuretics. These innovations are crucial for patients suffering from conditions related to aldosterone.
Career Highlights
Throughout his career, Gussin has worked with the American Cyanamid Company, where he has been able to apply his expertise in pharmaceutical development. His work has contributed to advancements in medical treatments, particularly in the area of diuretics.
Collaborations
Gussin has collaborated with notable colleagues such as John W Hanifin, Jr and Elliott Cohen. These partnerships have likely enhanced the quality and scope of his research and innovations.
Conclusion
Robert Zalmon Gussin's contributions to the field of pharmaceuticals through his patents and collaborations highlight his importance as an inventor. His work continues to influence medical treatments and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile